Expression profiling and pathway analysis of microRNA expression in the lungs of mice exposed to long-term, low-dose benzo(a)pyrene

Molecular and Cellular Toxicology

Volumn 10, Issue 1, 2014, Pages 67-74

  Zhang, Yanqiu ^a   Wang, Xikai ^a   Fu, Yanyun ^a   Yin, Lihong ^a   Pu, Yuepu ^a   Liang, Geyu ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Benzo(a)pyrene; Expression profile; MicroRNAs; Pathway; Sequencing

Indexed keywords

BENZO[A]PYRENE; MICRORNA; OLIVE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH THROUGHPUT SEQUENCING; LONG TERM EXPOSURE; LUNG; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA ISOLATION; SIGNAL TRANSDUCTION;

EID: 84901189957     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-014-0008-9     Document Type: Article

References (38)

1. Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H. & Loeb, L. A. Environmental and chemical carcinogenesis. Seminars in Cancer Biology 14:473-486 (2004).
2. Halappanavar, S. et al. Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage. Toxicology 285:133-141 (2011).
3. Croce, C. M. & Calin, G. A. miRNAs, cancer, and stem cell division. Cell 122:6-7 (2005).
4. Du, T. & Zamore, P. D. MicroPrimer: the biogenesis and function of microRNA. Development 132:4645-4652 (2005).
5. Skaftnesmo, K. O., Prestegarden, L., Micklem, D. R. & Lorens, J. B. MicroRNAs in tumorigenesis. Curr Pharm Biotechnol 8:320-325 (2007).
6. Hernando, E. microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clinical Translational Oncology 9:55-160 (2007).
7. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435:834-838 (2005).
8. Zhang, B. & Pan, X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environment Health Perspect 117:231-240 (2009).
9. Pogribny, I. P. et al. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619:30-37 (2007).
10. Izzotti, A. et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23:806-812 (2009).
11. Chen, T., Mally, A., Ozden, S. & Chipman, J. K. Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Environ Health Perspect 118:1597-1602 (2010).
12. Jardim, M. J., Fry, R. C., Jaspers, I., Dailey, L. & Diaz-Sanchez, D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect 117:1745-1751 (2009).
13. Gaidatzis, D., Van Nimwegen, E., Hausser, J. & Zavolan, M. Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics 8:69 (2007).
14. Gusev, Y., Schmittgen, T. D., Lerner, M., Postier, R. & Brackett, D. Computational analysis of biological functions and pathways collectively targeted by CO-expressed microRNAs in cancer. BMC Bioinformatics 8:(Suppl7)S16 (2007).
15. Jemal, A. et al. Cancer statistics. CA Cancer J Clin 59:225-249 (2009).
16. Johnson, C. D. et al. The let-7 miRNAs represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722 (2007).
17. Büssing, I., Slack, F. J. & Grosshans, H. Let-7 micro RNAs in development, stem cells and cancer. Trends Mol Med 14:400-409 (2008).
18. Takamizawa, J. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756 (2004).
19. Boyerinas, B. et al. Identification of let-7-regulated oncofetal genes. Cancer Res 68:2587-2591 (2008).
20. Ding, X. C., Slack, F. J. & Grosshans, H. The let-7 miRNAs interfaces extensively with the translation machinery to regulate cell differentiation. Cell Cycle 7:3083-3090 (2008).
21. Huang, Y. et al. Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers 17:435-440 (2012).
22. Cheung, T. H. et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11:2876-2884 (2012).
23. Wang, X. et al. Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression. Reprod Biomed Online 25:415-424 (2012).
24. Duan, H., Jiang, Y., Zhang, H. & Wu, Y. MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo(a)pyrene. Toxicol In Vitro 24:928-935 (2010).
25. Chen, J. Y., Wang, C. & Wang, J. MAPK signaling pathway research progress. Chinese Medical Sciences 1:32-34 (2011).
26. Wang, W., Ren, L. & Wang, J. N. The relationship of MAPK signaling pathway and apoptosis. Chinese Medicine 5:260-261 (2010).
27. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. & Sporn, M. B. Transforming growth factorbeta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160 (1983).
28. Surendran, K., Schiavi, S. & Hruska, K. A. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction and recombinant secreted frizzled related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16:2373-2784 (2005).
29. Howard, B. & Ashworth, A. Signaling pathways implicated in early mammary gland morphogenesis and breast cancer. PloS Genet 2:e112 (2006).
30. Heitman, J., Movva, N. R. & Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Scinece 253:905-909 (1991).
31. Zheng, P. S. & Ji, J. mTOR signaling pathway with tumor progress. Xi'an Jiaotong University (Medical Sciences) 31:1-9 (2010).
32. Mascaux, C. et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br. J. Cancer 92: 131-139 (2006).
33. Ludovini, V. et al. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. Journal of Thoracic Oncology 6:707-15 (2011).
34. Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274 (2007).
35. Brognard, J., Clark, A. S., Ni, Y. & Dennis, P. A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61:3986-3997 (2001).
36. Zhou, C. et al. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis. Tumour Biol 34:3831-3837 (2013).
37. Hsia, T. C. et al. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients. Anticancer Res 31:3601-3605 (2011).
38. Papadopoulos, G. L., Alexiou, P., Maragkakis, M., Reczko, M. & Hatzigeorgiou, A. G. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatic Applications Note 25:1991-1993 (2009).